Eterna Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1 |
Gross Profit | 0 | -55 | -69 | 1 |
EBITDA | -1,186 | -2,446 | -2,661 | -2,197 |
EBIT | -1,203 | -2,501 | -2,730 | -2,265 |
Net Income | -1,240 | -3,139 | -8,202 | -5,759 |
Net Change In Cash | 0 | 0 | 0 | 1 |
Free Cash Flow | -1,294 | -2,532 | -2,065 | -3,545 |
Cash | 3,047 | 4,315 | 1,918 | 1,729 |
Basic Shares | 8,226 | 5,179 | 3,557 | 3,425 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $582 | $68 | $0 | $0 |
Gross Profit | 486 | -168 | -497 | -459 |
EBITDA | -36,119 | -19,934 | -24,007 | -121,948 |
EBIT | -37,757 | -21,057 | -24,504 | -122,407 |
Net Income | -44,539 | -21,668 | -24,579 | -122,545 |
Net Change In Cash | 582 | 68 | 0 | 0 |
Free Cash Flow | -16,205 | -20,427 | -21,273 | -23,642 |
Cash | 1,729 | 7,575 | 11,446 | 16,985 |
Basic Shares | 909 | 354 | 203 | 144 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.61 |
2025-03-31 | -$2.31 |
2024-12-31 | -$0.15 |
2023-09-30 | -$1.03 |
